Cellectis - ADR

XNAS:CLLS   4:00:00 PM EDT
1.56
+0.05 (+3.31%)
: $1.55 -0.01 (-0.64%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)112.83M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$15.61 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$1.87
50-Day MA$2.78
200-Day MA$3.53
See more pivots

Cellectis - ADR Stock, XNAS:CLLS

8, rue de la Croix Jarry, Paris, Ile-de-France 75013
France
Phone: +33.1.81.69.16.00
Number of Employees: 222
http://www.cellectis.com

Description

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and Andr�© Choulika on February 20, 1999 and is headquartered in Paris, France.